UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 26, 2021
Global Tech Industries Group, Inc.
(Exact name of registrant as specified in its charter)
| Nevada | | 000-10210 | | 83-0250943 |
| (State or Other Jurisdiction | | (Commission | | (I.R.S. Employer |
| of Incorporation) | | File Number) | | Identification No.) |
511 Sixth Avenue, Suite 800 New York, NY 10011
(Address of Principal Executive Offices) (Zip Code)
(212) -204-7926
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None.
Securities registered pursuant to Section 12(g) of the Act:
| Title of each Class | | Trading Symbol | | Name of each exchange on which registered |
| Common Stock | | GTII | | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 1.01 Entry into A Definitive Material Agreement
On May 26, 2021, Global Tech Industries Group, Inc., (“GTII” or the “Company”), signed a binding letter agreement expanding the business combination originally entered into with My RetinaDocs LLC (“My Retina”), on April 30, 2021. The expanded combination now includes Eyecare and Eyewear, Inc. (“E&E”), a mobile diagnostic company providing diabetes- related eye care testing. The expanded agreement provides for the issuance of 1,150,000 additional common shares of GTII stock to the My Retina and E&E shareholders, bringing the total of common shares issued between the original and expanded agreements to 1,500,000 common shares. The agreement is subject to the successful completion of a two-year audit, inclusive of the starting balance sheet as of January 1, 2021 by a PCAOB independent public accountant approved by GTII and is expected to close within thirty days, assuming all closing conditions are met.
Item 9.01 (d) Exhibits
10.1 Letter Agreement by and between Global Tech Industries Group, Inc. My RetinaDocs, LLC, and Eyecare and Eyewear, Inc.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | Global Tech Industries Group, Inc. |
| | |
| Date: June 2, 2021 | By: | /s/ David Reichman |
| | | Chairman & CEO |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
